arrow_back Back to App

Call to Lower Prescription Drug Costs in the US

The US Senate urges the President and the Secretary of Health to take action to reduce prescription drug prices. This aims to ease the financial burden on citizens who often forgo treatment or basic necessities due to high medication costs. These actions are intended to improve drug accessibility and protect public health.
Key points
High prescription drug prices in the US are significantly higher than in other countries, leading to financial and health issues for citizens.
Many Americans ration medication or sacrifice other necessities to cover treatment costs, worsening their health.
The Senate calls for using existing authorities, such as licensing generic competition and price controls, to lower drug costs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_151
Sponsor: Sen. Merkley, Jeff [D-OR]
Process start date: 2021-04-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution calling on the President and the Secretary of Health and Human Services to take action to lower prescription drug costs.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_151.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-13.

What are the main provisions?

Key points include:

  • High prescription drug prices in the US are significantly higher than in other countries, leading to financial and health issues for citizens.
  • Many Americans ration medication or sacrifice other necessities to cover treatment costs, worsening their health.
  • The Senate calls for using existing authorities, such as licensing generic competition and price controls, to lower drug costs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Merkley, Jeff [D-OR].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Economy